266 related articles for article (PubMed ID: 11732406)
1. [A new antibiotic against respiratory tract infections. More power against pneumococci].
MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
[No Abstract] [Full Text] [Related]
2. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
Soriano F
Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745
[No Abstract] [Full Text] [Related]
3. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M
J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763
[TBL] [Abstract][Full Text] [Related]
4. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
Carter PL
Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae.
Okamoto H; Miyazaki S; Tateda K; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2001 Nov; 45(11):3250-2. PubMed ID: 11600393
[TBL] [Abstract][Full Text] [Related]
6. Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections.
Bingen E; Doit C; Loukil C; Brahimi N; Bidet P; Deforche D; Geslin P
Antimicrob Agents Chemother; 2003 Jul; 47(7):2345-7. PubMed ID: 12821495
[TBL] [Abstract][Full Text] [Related]
7. [Resistance of respiratory tract infection agents is still increasing. Is its time for new antibiotic strategies?].
MMW Fortschr Med; 2003 Feb; 145(9):55. PubMed ID: 12666535
[No Abstract] [Full Text] [Related]
8. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
[No Abstract] [Full Text] [Related]
9. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
Garau J
Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
[TBL] [Abstract][Full Text] [Related]
10. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
Brauers J; Ewig S; Kresken M
Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
[TBL] [Abstract][Full Text] [Related]
11. Hidden epidemic of macrolide-resistant pneumococci.
Klugman KP; Lonks JR
Emerg Infect Dis; 2005 Jun; 11(6):802-7. PubMed ID: 15963272
[TBL] [Abstract][Full Text] [Related]
12. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
Poirier R
Presse Med; 1998 Sep; 27 Suppl 4():14-5. PubMed ID: 9798478
[No Abstract] [Full Text] [Related]
13. Resistant pneumococcal infections.
Koornhof HJ; Jacobs MR
Compr Ther; 1979 May; 5(5):69-74. PubMed ID: 37022
[No Abstract] [Full Text] [Related]
14. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
15. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
[TBL] [Abstract][Full Text] [Related]
16. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
Soriano F; Fernández-Roblas R
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
[No Abstract] [Full Text] [Related]
17. [Antibacterial therapy of pneumococcal infections caused by drug resistant microorganisms].
Sidorenko SV
Antibiot Khimioter; 2002; 47(7):31-7. PubMed ID: 12516194
[No Abstract] [Full Text] [Related]
18. Telithromycin (Ketek) for respiratory infections.
Med Lett Drugs Ther; 2004 Aug; 46(1189):66-8. PubMed ID: 15314586
[No Abstract] [Full Text] [Related]
19. Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
Chiou CC; Hseih KS
Acta Paediatr Taiwan; 2003; 44(2):67-74. PubMed ID: 12845845
[TBL] [Abstract][Full Text] [Related]
20. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3.
Jenkins SG; Farrell DJ; Patel M; Lavin BS
J Infect; 2005 Dec; 51(5):355-63. PubMed ID: 15950288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
